Qirui Pharmaceutical Selected for Inclusion in the 2023 Jiangxia District List of Proposed Projects for District-Level Technology Transfer and Key R&D Initiatives

Recently, in accordance with the spirit of documents including the “Several Opinions on Promoting Scientific and Technological Innovation and High-Quality Development of the Industrial Economy,” the “Provisional Implementation Rules for Rewarding Enterprises in Jiangxia District for Undertaking Major Projects,” the “Notice of Jiangxia District on Organizing and Implementing the 2023 District-Level Science and Technology Achievement Transformation Projects and District-Level Key R&D Program Projects,” and the “Public Notice of the Preliminary Review of the 2023 Science and Technology Achievement Transformation Projects and District-Level Key R&D Program Projects by the District Science, Technology and Economic Information Bureau,” the Jiangxia District Bureau of Science, Technology and Economic Information has publicly announced the list of proposed projects to be approved for the 2023 district-level science and technology achievement transformation program and the district-level key R&D program. Among them, the project “Research on Key Technologies for Ademetionine Disulfonate Active Pharmaceutical Ingredient and Preparations” submitted by Wuhan Qirui Pharmaceutical Co., Ltd. has been successfully selected.

（ List of Proposed Projects for Approval under the 2023 District-Level Science and Technology Achievement Transformation Program and the District-Level Key R&D Program in Jiangxia District , in no particular order)

The commercialization of scientific and technological achievements refers to the subsequent activities—such as further experimentation, development, application, and promotion—undertaken to translate scientifically and technologically developed成果 with practical value into new products, new processes, new materials, and new industries, thereby enhancing productivity. In the 2023 list of proposed projects for district-level technology transfer and key district-level R&D programs in Jiangxia District, after expert review, defense presentations, and deliberation by the Party Leadership Group of the Bureau, only seven projects were approved, including pilot-scale testing and industrial application of a novel antibiotic-replacement biological preparation.

With the rapid development of the global economy, science and technology have become the engine of economic growth, and facilitating the transformation of scientific and technological achievements into practical applications while accelerating their industrialization has emerged as a new trend in national science and technology policies worldwide.

Looking ahead, Qirui Pharmaceutical will remain focused on research in critical technology areas, intensify efforts to master key core technologies, vigorously promote the local translation and industrialization of scientific and technological achievements, stimulate the enthusiasm of research personnel, strengthen the alignment of supply and demand, consolidate its competitive advantages, and facilitate the transformation of more scientific and technological breakthroughs into real productive forces, thereby achieving further outstanding results on the path of high-quality development for the Qirui Group.